Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
PaperCitations, authors & open-access status
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 578 citations, 2021 year and bronze oa status.
578
Citations
2021
Year
bronze
OA Status